$1.10
At close: Apr 17 EDT
$1.11
0.010.91%
Pre-Market: 4:06 AM EDT
Comments
Loading...
C4 Therapeutics (CCCC) Forecast
NewsEarningsC4 Therapeutics (CCCC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
C4 Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CCCC | Benzinga
Explore C4 Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CCCC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy C4 Therapeutics (CCCC) stock?
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Who are C4 Therapeutics (CCCC) competitors?
Other companies in C4 Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), OncoCyte (NASDAQ:OCX), Atossa Therapeutics (NASDAQ:ATOS) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for C4 Therapeutics (CCCC) stock?
C4 Therapeutics has a consensus price target of $10.82.
What is the current price for C4 Therapeutics (CCCC)?
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $1.11 last updated April 17, 2025 at 4:06 AM EDT.
Does C4 Therapeutics (CCCC) pay a dividend?
There are no upcoming dividends for C4 Therapeutics.
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is C4 Therapeutics (CCCC) going to split?
There is no upcoming split for C4 Therapeutics.
What sector and industry does C4 Therapeutics (CCCC) operate in?
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.